This text on the future of American biomedical research explores such issues as: the prospects for government support of biomedical research; funding disease-based research versus untargeted basic research; and the growing alliance between universities and corporations in biomedical research.
The authors explore the prospects for government support of biomedical research in an era of federal downsizing; the merits of funding disease-based research versus untargeted basic research; the promise and challenges of the growing alliance between universities and corporations in biomedical research; and the complicated issues related to the granting of intellectual property rights for publicly funded research.Contributors to this volume include Harold Varmus, director of the National Institutes of Health; former senator Mark Hatfield, Republican of Oregon; Bruce Alberts, president, National Academy of Sciences; June O'Neill, director, Congressional Budget Office; R. Glenn Hubbard, Columbia University; Michael Darby and Lynne Zucker, University of California, Los Angeles; Frank Lichtenberg, Columbia University; Rebecca Eisenberg, University of Michigan Law School; Clarisa Long, American Enterprise Institute; Richard Johnson, Arnold and Porter; and Purnell W. Choppin, president, Howard Hughes Medical Institute.
"Sobre este título" puede pertenecer a otra edición de este libro.
(Ningún ejemplar disponible)
Buscar: Crear una peticiónSi conoce el autor y el título del libro pero no lo encuentra en IberLibro, nosotros podemos buscarlo por usted e informarle por e-mail en cuanto el libro esté disponible en nuestras páginas web.
Crear una petición